Written answers
Tuesday, 5 November 2019
Department of Health
Medicinal Products Regulation
Bobby Aylward (Carlow-Kilkenny, Fianna Fail)
Link to this: Individually | In context | Oireachtas source
563. To ask the Minister for Health when the final report on valproate will be published; the reason for the delay in finalising same to date; and if he will make a statement on the matter. [44692/19]
Bobby Aylward (Carlow-Kilkenny, Fianna Fail)
Link to this: Individually | In context | Oireachtas source
564. To ask the Minister for Health if he will meet representative bodies to discuss progress on recommendations in a report (details supplied); and if he will make a statement on the matter. [44693/19]
Bobby Aylward (Carlow-Kilkenny, Fianna Fail)
Link to this: Individually | In context | Oireachtas source
565. To ask the Minister for Health the position regarding the apparent lack of availability of official documentation regarding the licensing of a drug (details supplied) within the public sphere; his views on the need for total transparency in respect of same and the need for a possible investigation in respect of same; and if he will make a statement on the matter. [44694/19]
Simon Harris (Wicklow, Fine Gael)
Link to this: Individually | In context | Oireachtas source
I propose to take Questions Nos. 563 to 565, inclusive, together.
I am due to receive a briefing on the HSE's Valproate Response Project report shortly. No decision has been taken regarding potential publication of the report.
I am advised that some documentation regarding the licensing of Epilim has previously been shared with the representative body referred to by the Deputy. I will ask Department and Health Products Regulatory Authority (HPRA) officials to consider whether additional documents could be released. I am also happy to consider a meeting with the representative bodies referred to by the Deputy if a request is submitted to my office in the Department.
No comments